DARSHANKUMAR ASHWINBHAI DAVE MD
Prescription History 1033155437
Psychiatry & Neurology - Neurology in Charleston, WV


Quality Rating: 98.31 out of 100 score

NPI Status: Active since June 22, 2006

Contact Information

3100 MACCORKLE AVE SE
SUITE 802
CHARLESTON, WV
ZIP 25304
Phone: (304) 343-4400
Fax: (304) 345-5005

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DARSHANKUMAR ASHWINBHAI DAVE MD, an active Neurology specialist practicing in Charleston, WV. Our medical registry currently tracks 27 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 905 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydrocodone-Acetaminophen, which accounts for 130 claims alone.


Aimovig Autoinjector

Generic Formulation: Erenumab-AooeSpecialty: Neurology
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 630
WV State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills41.5
Peer Average Days Supply1,239
Conservative Utilization

This provider writes prescriptions for this formulation 40.0% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,462.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$783.93

State Avg Cost Per Claim

$884.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Erenumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks.

Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 21.0
Days Supply 630
WV State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills57.5
Peer Average Days Supply1,703
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.6% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $226.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.12

State Avg Cost Per Claim

$21.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Baclofen

Generic Formulation: BaclofenSpecialty: Neurology
Provider Metrics Summary
Total Claims 18
30-Day Fills 28.0
Days Supply 840
WV State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills45.2
Peer Average Days Supply1,258
Conservative Utilization

This provider writes prescriptions for this formulation 43.8% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $433.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.11

State Avg Cost Per Claim

$31.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Carbidopa-Levodopa

Generic Formulation: Carbidopa/LevodopaSpecialty: Neurology
Provider Metrics Summary
Total Claims 58
30-Day Fills 82.1
Days Supply 2,389
WV State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills88.8
Peer Average Days Supply2,505
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,240.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.38

State Avg Cost Per Claim

$35.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 49
30-Day Fills 55.0
Days Supply 1,650
WV State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills48.2
Peer Average Days Supply1,268
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 32.4% more claims than the standard regional baseline profile for WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $352.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.20

State Avg Cost Per Claim

$16.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Divalproex Sodium

Generic Formulation: Divalproex SodiumSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 25.0
Days Supply 734
WV State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills59.7
Peer Average Days Supply1,530
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.6% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $431.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$28.76

State Avg Cost Per Claim

$46.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 41
30-Day Fills 71.0
Days Supply 2,130
WV State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills84.5
Peer Average Days Supply2,400
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $404.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.87

State Avg Cost Per Claim

$13.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 19
30-Day Fills 25.0
Days Supply 750
WV State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills118.5
Peer Average Days Supply3,500
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.8% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $232.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.24

State Avg Cost Per Claim

$39.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurology
Provider Metrics Summary
Total Claims 104
30-Day Fills 138.0
Days Supply 4,140
WV State Average Benchmarks
Peer Average Claims118.0
Peer Average 30-Day Fills153.8
Peer Average Days Supply4,347
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,010.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.33

State Avg Cost Per Claim

$18.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Gammagard Liquid

Generic Formulation: Immun Glob G(Igg)/Gly/Iga Ov50Specialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 649
WV State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.8
Peer Average Days Supply505
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $256,012.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$10,667.20

State Avg Cost Per Claim

$8,292.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP). Platelets are needed to stop bleeding and form blood clots. Some immune globulin products may also be used to treat certain types of muscle weakness problem (multifocal motor neuropathy, dermatomyositis) or a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). Some products may also be used to prevent certain blood vessel disorders in people with Kawasaki syndrome.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Neurology
Provider Metrics Summary
Total Claims 130
30-Day Fills 130.0
Days Supply 3,777
WV State Average Benchmarks
Peer Average Claims103.0
Peer Average 30-Day Fills103.6
Peer Average Days Supply2,210
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.2% more claims than the standard regional baseline profile for WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,728.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.99

State Avg Cost Per Claim

$20.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Lacosamide

Generic Formulation: LacosamideSpecialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 30.1
Days Supply 867
WV State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills36.7
Peer Average Days Supply975
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,760.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$115.01

State Avg Cost Per Claim

$291.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.

Therapeutic Applications

Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 34.0
Days Supply 1,020
WV State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills74.6
Peer Average Days Supply2,176
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.9% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $632.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.37

State Avg Cost Per Claim

$15.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Levetiracetam

Generic Formulation: LevetiracetamSpecialty: Neurology
Provider Metrics Summary
Total Claims 62
30-Day Fills 116.0
Days Supply 3,480
WV State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills69.8
Peer Average Days Supply1,964
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 29.2% more claims than the standard regional baseline profile for WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,195.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$51.54

State Avg Cost Per Claim

$35.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Memantine Hcl

Generic Formulation: Memantine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 31.0
Days Supply 921
WV State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills63.9
Peer Average Days Supply1,784
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 65.9% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $267.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.85

State Avg Cost Per Claim

$37.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Nurtec Odt

Generic Formulation: Rimegepant SulfateSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 196
WV State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills28.1
Peer Average Days Supply664
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.3% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,844.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$985.88

State Avg Cost Per Claim

$1,244.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to prevent or treat migraine. Rimegepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (such as nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications.

Oxcarbazepine

Generic Formulation: OxcarbazepineSpecialty: Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 22.7
Days Supply 665
WV State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills44.2
Peer Average Days Supply1,264
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.9% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $715.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$44.74

State Avg Cost Per Claim

$50.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.

Therapeutic Applications

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Phenobarbital

Generic Formulation: PhenobarbitalSpecialty: Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 16.1
Days Supply 484
WV State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills29.1
Peer Average Days Supply764
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $512.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$42.67

State Avg Cost Per Claim

$35.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.

Therapeutic Applications

This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Phenobarbital belongs to a class of drugs known as barbiturate anticonvulsants/hypnotics. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. This medication is also used for a short time (usually no more than 2 weeks) to help calm you or help you sleep during periods of anxiety. It works by affecting certain parts of the brain to cause calming.

Primidone

Generic Formulation: PrimidoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 37
30-Day Fills 58.5
Days Supply 1,739
WV State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills58.7
Peer Average Days Supply1,713
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,349.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$36.46

State Avg Cost Per Claim

$23.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.

Therapeutic Applications

This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Primidone belongs to a class of drugs known as barbiturate anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

Privigen

Generic Formulation: Immun Glob G(Igg)/Pro/Iga 0-50Specialty: Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 336
WV State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills18.3
Peer Average Days Supply481
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $163,362.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$13,613.57

State Avg Cost Per Claim

$7,417.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to boost the body's natural defense system against infection in persons with a weakened immune system (primary immune deficiency). Immune globulin contains natural substances called antibodies (a type called IgG) that come from healthy human blood (plasma). These antibodies help protect your body against infections and help you to fight an infection if you get sick. Some immune globulin products may also be used to treat a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP).

Rizatriptan

Generic Formulation: Rizatriptan BenzoateSpecialty: Neurology
Provider Metrics Summary
Total Claims 34
30-Day Fills 36.0
Days Supply 900
WV State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills24.2
Peer Average Days Supply593
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 61.9% higher than the standard regional baseline profile for WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $500.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.73

State Avg Cost Per Claim

$31.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Rizatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Rizatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Rizatriptan does not prevent future migraines or lessen how often you get migraine attacks.

Ropinirole Hcl

Generic Formulation: Ropinirole HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 51
30-Day Fills 85.0
Days Supply 2,550
WV State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills72.1
Peer Average Days Supply2,122
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 34.2% more claims than the standard regional baseline profile for WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $954.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.72

State Avg Cost Per Claim

$16.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat Parkinson's disease. It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move (on-off syndrome). Ropinirole works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

Sumatriptan Succinate

Generic Formulation: Sumatriptan SuccinateSpecialty: Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 18.0
Days Supply 493
WV State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills24.2
Peer Average Days Supply586
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $160.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.03

State Avg Cost Per Claim

$24.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.

Therapeutic Applications

Sumatriptan is used to treat migraines and cluster headaches. It helps to relieve pain and other symptoms of migraines/headaches including sensitivity to light or sound, nausea, and vomiting. Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. It does not prevent future migraines/headaches or reduce how often you may get a headache. Sumatriptan belongs to a group of drugs called triptans. It affects a certain natural chemical (serotonin) that constricts blood vessels in the brain. It may also block other pain pathways in the brain.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 35.0
Days Supply 1,050
WV State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills61.6
Peer Average Days Supply1,701
Conservative Utilization

This provider writes prescriptions for this formulation 45.5% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $488.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.34

State Avg Cost Per Claim

$13.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Topiramate

Generic Formulation: TopiramateSpecialty: Neurology
Provider Metrics Summary
Total Claims 42
30-Day Fills 57.0
Days Supply 1,655
WV State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills55.7
Peer Average Days Supply1,645
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 27.3% more claims than the standard regional baseline profile for WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $614.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.64

State Avg Cost Per Claim

$16.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
WV State Average Benchmarks
Peer Average Claims71.0
Peer Average 30-Day Fills72.9
Peer Average Days Supply1,649
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.5% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $66.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.02

State Avg Cost Per Claim

$8.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Zonisamide

Generic Formulation: ZonisamideSpecialty: Neurology
Provider Metrics Summary
Total Claims 20
30-Day Fills 33.0
Days Supply 990
WV State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills48.3
Peer Average Days Supply1,413
Conservative Utilization

This provider writes prescriptions for this formulation 35.5% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $756.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$37.82

State Avg Cost Per Claim

$28.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.

Therapeutic Applications

Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DARSHANKUMAR ASHWINBHAI DAVE MD provides transparency into local medical care patterns within Charleston, WV.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.